157 related articles for article (PubMed ID: 15974917)
1. Role of fractalkine (CX3CL1) in regulating neuron-microglia interactions: development of viral-based CX3CR1 antagonists.
Streit WJ; Davis CN; Harrison JK
Curr Alzheimer Res; 2005 Apr; 2(2):187-9. PubMed ID: 15974917
[TBL] [Abstract][Full Text] [Related]
2. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the fractalkine chemokine domain. Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion.
Harrison JK; Fong AM; Swain PA; Chen S; Yu YR; Salafranca MN; Greenleaf WB; Imai T; Patel DD
J Biol Chem; 2001 Jun; 276(24):21632-41. PubMed ID: 11278650
[TBL] [Abstract][Full Text] [Related]
4. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia.
Harrison JK; Jiang Y; Chen S; Xia Y; Maciejewski D; McNamara RK; Streit WJ; Salafranca MN; Adhikari S; Thompson DA; Botti P; Bacon KB; Feng L
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10896-901. PubMed ID: 9724801
[TBL] [Abstract][Full Text] [Related]
5. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
[TBL] [Abstract][Full Text] [Related]
6. An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.
Milligan E; Zapata V; Schoeniger D; Chacur M; Green P; Poole S; Martin D; Maier SF; Watkins LR
Eur J Neurosci; 2005 Dec; 22(11):2775-82. PubMed ID: 16324111
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine: moving from chemotaxis to neuroprotection.
Ré DB; Przedborski S
Nat Neurosci; 2006 Jul; 9(7):859-61. PubMed ID: 16801915
[No Abstract] [Full Text] [Related]
8. Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?
Nishiyori A; Minami M; Ohtani Y; Takami S; Yamamoto J; Kawaguchi N; Kume T; Akaike A; Satoh M
FEBS Lett; 1998 Jun; 429(2):167-72. PubMed ID: 9650583
[TBL] [Abstract][Full Text] [Related]
9. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
[TBL] [Abstract][Full Text] [Related]
10. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.
Zhuang ZY; Kawasaki Y; Tan PH; Wen YR; Huang J; Ji RR
Brain Behav Immun; 2007 Jul; 21(5):642-51. PubMed ID: 17174525
[TBL] [Abstract][Full Text] [Related]
11. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS.
Hughes PM; Botham MS; Frentzel S; Mir A; Perry VH
Glia; 2002 Mar; 37(4):314-27. PubMed ID: 11870871
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.
Cotter R; Williams C; Ryan L; Erichsen D; Lopez A; Peng H; Zheng J
J Neurovirol; 2002 Dec; 8(6):585-98. PubMed ID: 12476352
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat disrupts CX3CL1-CX3CR1 axis in microglia via the NF-κBYY1 pathway.
Duan M; Yao H; Cai Y; Liao K; Seth P; Buch S
Curr HIV Res; 2014; 12(3):189-200. PubMed ID: 24862326
[TBL] [Abstract][Full Text] [Related]
14. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats.
Milligan ED; Zapata V; Chacur M; Schoeniger D; Biedenkapp J; O'Connor KA; Verge GM; Chapman G; Green P; Foster AC; Naeve GS; Maier SF; Watkins LR
Eur J Neurosci; 2004 Nov; 20(9):2294-302. PubMed ID: 15525271
[TBL] [Abstract][Full Text] [Related]
15. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions.
Verge GM; Milligan ED; Maier SF; Watkins LR; Naeve GS; Foster AC
Eur J Neurosci; 2004 Sep; 20(5):1150-60. PubMed ID: 15341587
[TBL] [Abstract][Full Text] [Related]
16. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.
Lindia JA; McGowan E; Jochnowitz N; Abbadie C
J Pain; 2005 Jul; 6(7):434-8. PubMed ID: 15993821
[TBL] [Abstract][Full Text] [Related]
17. FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats.
Zhou Y; Zhang L; Hao Y; Yang L; Fan S; Xiao Z
J Headache Pain; 2022 Apr; 23(1):42. PubMed ID: 35382731
[TBL] [Abstract][Full Text] [Related]
18. Use of cocultured cell systems to elucidate chemokine-dependent neuronal/microglial interactions: control of microglial activation.
Zujovic V; Taupin V
Methods; 2003 Apr; 29(4):345-50. PubMed ID: 12725801
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of fractalkine ameliorates murine collagen-induced arthritis.
Nanki T; Urasaki Y; Imai T; Nishimura M; Muramoto K; Kubota T; Miyasaka N
J Immunol; 2004 Dec; 173(11):7010-6. PubMed ID: 15557198
[TBL] [Abstract][Full Text] [Related]
20. Sensory lesioning induces microglial synapse elimination via ADAM10 and fractalkine signaling.
Gunner G; Cheadle L; Johnson KM; Ayata P; Badimon A; Mondo E; Nagy MA; Liu L; Bemiller SM; Kim KW; Lira SA; Lamb BT; Tapper AR; Ransohoff RM; Greenberg ME; Schaefer A; Schafer DP
Nat Neurosci; 2019 Jul; 22(7):1075-1088. PubMed ID: 31209379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
